Soinsvie Pharmacia Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-01-2025
- Paid Up Capital ₹ 0.10 M
as on 04-01-2025
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 13.78%
(FY 2023)
- Profit 58.01%
(FY 2023)
- Ebitda 3458.49%
(FY 2023)
- Net Worth 33.49%
(FY 2023)
- Total Assets 18.31%
(FY 2023)
About Soinsvie Pharmacia
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dinesh Gupta and Amanjeet Singh serve as directors at the Company.
- CIN/LLPIN
U24100HR2015PTC054914
- Company No.
054914
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Soinsvie Pharmacia Private Limited offer?
Soinsvie Pharmacia Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Cholesterol Medicine, Nutraceuticals & Dietary Supplements, Mineral Supplement, Multivitamin Tablets & Capsules, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Pharma & Bioanalytical Services, PCD Pharma Franchise, Anti Infective Drugs & Medicines.
Who are the key members and board of directors at Soinsvie Pharmacia?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Gupta  | Director | 17-Mar-2015 | Current |
| Amanjeet Singh | Director | 17-Mar-2015 | Current |
Financial Performance of Soinsvie Pharmacia.
Soinsvie Pharmacia Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.78% increase. The company also saw a substantial improvement in profitability, with a 58.01% increase in profit. The company's net worth Soared by an impressive increase of 33.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Soinsvie Pharmacia?
In 2023, Soinsvie Pharmacia had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Soinsvie Pharmacia?
Unlock and access historical data on people associated with Soinsvie Pharmacia, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Soinsvie Pharmacia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Soinsvie Pharmacia's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
